financetom
Business
financetom
/
Business
/
Salesforce says customer data possibly exposed following incident
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce says customer data possibly exposed following incident
Nov 20, 2025 5:36 PM

WASHINGTON (Reuters) -Salesforce ( CRM ) said Thursday it is investigating "unusual activity" involving Gainsight-published applications that may have exposed customer data.

In a brief statement published to its status portal, Salesforce ( CRM ) said the Gainsight-published applications, which are installed and managed by customers "may have enabled unauthorized access to certain customers' Salesforce ( CRM ) data."

Salesforce ( CRM ) said in its message that it had temporarily "revoked all active access" to Gainsight's applications. In an email, the company noted that, "There is no indication that this issue resulted from any vulnerability in the Salesforce ( CRM ) platform."

Gainsight said on its website that "we continue to work closely with Salesforce ( CRM ) as they investigate the unusual activity that led to the revocation of access tokens for Gainsight-published applications." Gainsight didn't immediately return an email for further comment.

Although Reuters could not establish the scope or nature of the incident, hackers have repeatedly exploited the integrations between software-as-service companies like Salesforce ( CRM ) and Gainsight to steal data.

Last month, Alphabet's Google said that the exploitation of a weakness at Oracle's E-Business Suite of applications had likely impacted more than 100 companies. In June, Google said hackers had tricked employees of Salesforce ( CRM ) clients into installing a modified version of Salesforce's ( CRM ) Data Loader, a proprietary tool used to bulk import files, and compromising their data.

Jaime Vasco, the cofounder of Nudge Security, said it was part of an emerging paradigm.

"Attackers don't need to breach the core platform when they can compromise an integration with privileged access," he said in a post on LinkedIn. Speaking to Reuters, he said: "This is the new attack surface."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Carvana Stock Thursday?
What's Going On With Carvana Stock Thursday?
Apr 11, 2024
Carvana Co ( CVNA ) shares are moving lower. The stock appears to be trading down in sympathy with shares of competitor CarMax Inc ( KMX ) , which fell on worse-than-expected earnings results. What Happened With KMX: Carmax ( KMX ) reported fourth-quarter revenue of $5.63 billion, which missed the consensus estimate of $5.79 billion, according to Benzinga Pro....
National Bank of Canada Says G Mining's Tocantinzinho Project 89% Complete
National Bank of Canada Says G Mining's Tocantinzinho Project 89% Complete
Apr 11, 2024
11:33 AM EDT, 04/11/2024 (MT Newswires) -- National Bank of Canada said Thursday that G Mining Ventures's ( GMINF ) construction of the Tocantinzinho gold project in Brazil is 89% complete. The project's total progress is at 87%. Commercial production is expected in the second half. The bank said G Mining's ( GMINF ) update supports its top pick thesis...
Battalion Oil Shares Slump After Fury Resources Says Can't Meet Some Acquisition Funding Deadlines
Battalion Oil Shares Slump After Fury Resources Says Can't Meet Some Acquisition Funding Deadlines
Apr 11, 2024
11:37 AM EDT, 04/11/2024 (MT Newswires) -- Battalion Oil ( BATL ) shares fell about 17% in recent trading after the company said Thursday it was informed that Fury Resources would fail to meet some funding deadlines for the acquisition of Battalion. Battalion said in a regulatory filing that it is assessing its options, including possible changes to the merger...
What's Going On With Candel Therapeutics Stock?
What's Going On With Candel Therapeutics Stock?
Apr 11, 2024
Candel Therapeutics, Inc. ( CADL ) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. The Details: We recently reported data from the phase 2 randomized clinical trial of CAN-2409 in borderline resectable pancreatic cancer, showing that CAN-2409, when added to standard of care, more than doubled the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved